Seattle Biotech Acucela Inc. Sets Terms Of $162 Million Japanese IPO

Published: Feb 04, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Acucela said the underwriters of its initial public offering in Japan will sell 9.2 million shares at $17.65 apiece, raising about $143 million after expenses and discounts. Seattle biotechnology company Acucela said the underwriters of its initial public offering in Japan will sell 9.2 million shares at $17.65 apiece, raising about $143 million after expenses and discounts. The shares, which are not available to U.S. investors and won’t be traded here, have been approved for listing on the the Mothers market of the Tokyo Stock Exchange, Acucela said in a regulatory filing.

Help employers find you! Check out all the jobs and post your resume.

Back to news